Yeast surface display of a noncovalent MHC class II heterodimer complexed with antigenic peptide

Biotechnology and Bioengineering

Volumn 92, Issue 4, 2005, Pages 485-491

  Boder, Eric T ^a,b   Bill, Jerome R ^c,d   Nields, Andrew W ^a,b   Marrack, Philippa C ^c,d,e   Kappler, John W ^c,d,e  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Class II MHC; Heterodimer expression in yeast; Peptide loading; Protein engineering; Yeast display

Indexed keywords

ANTIGENS; COMPLEXATION; DIMERS; PROTEINS; REACTION KINETICS; YEAST;

CLASS II MHC; HETERODIMER EXPRESSION OF DIMER; PEPTIDE LOADING; PROTEIN ENGINEERING; YEAST DISPLAY;

BIOTECHNOLOGY;

ANTIGEN; HLA DR4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANTIBODY AFFINITY; ANTIGEN BINDING; ARTICLE; BIOTECHNOLOGY; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; COVALENT BOND; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR EVOLUTION; NONHUMAN; PEPTIDE ANALYSIS; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN ENGINEERING; PROTEIN STABILITY; SURFACE PROPERTY; WILD TYPE; YEAST;

ANTIBODIES, MONOCLONAL; GENE EXPRESSION; HLA-DR4 ANTIGEN; HUMANS; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE;

ANIMALIA; SACCHAROMYCES CEREVISIAE;

EID: 28444457689     PISSN: 00063592     EISSN: None     Source Type: Journal    
DOI: 10.1002/bit.20616     Document Type: Article

References (52)

1. Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ, Davis MM. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274(5284):94-96.
2. Arimilli S, Astafieva I, Mukku PV, Cardoso C, Deshpande S, Nag B. 1999. Peptide binding inhibits aggregation of soluble MHC class II in solution. IUBMB Life 48(5):483-491.
3. Arnold CE, Parekh RN, Yang W, Wittrup KD. 1998. Leader peptide efficiency correlates with signal recognition particle dependence in Saccharomyces cerevisiae. Biotechnol Bioeng 59(3):286-293.
4. Boder ET, Wittrup KD. 2000. Yeast surface display for directed evolution of protein expression, affinity, and stability. Methods Enzymol 328:430-444.
5. Boen E, Crownover AR, McIlhaney M, Korman AJ, Bill J. 2000. Identification of T cell ligands in a library of peptides covalently attached to HLA-DR4. J Immunol 165(4):2040-2047.
6. Bromley SK, Burack WR, Johnson KG, Somersalo K, Sims TN, Sumen C, Davis MM, Shaw AS, Allen PM, Dustin ML. 2001. The immunological synapse. Annu Rev Immunol 19:375-396.
7. Brophy SE, Holler PD, Kranz DM. 2003. A yeast display system for engineering functional peptide-MHC complexes. J Immunol Methods 272(1-2):235-246.
8. Chen W, Georgiou G. 2002. Cell-surface display of heterologous proteins: From high-throughput screening to environmental applications. Biotechnol Bioeng 79(5):496-503.
9. Chlewicki LK, Holler PD, Monti BC, Clutter MR, Kranz DM. 2005. High-affinity, peptide-specific T Cell receptors can be generated by mutations in CDR1, CDR2 or CDR3. J Mol Biol 346(1):223-239.
10. Crawford F, Kozono H, White J, Marrack P, Kappler J. 1998. Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity 8(6):675-682.
11. Cull MG, Schatz PJ. 2000. Biotinylation of proteins in vivo and in vitro using small peptide tags. Methods Enzymol 326:430-440.
12. Esteban O, Zhao H. 2004. Directed evolution of soluble single-chain human class II MHC molecules. J Mol Biol 340(1):81-95.
13. Ge Q, Stone JD, Thompson MT, Cochran JR, Rushe M, Eisen HN, Chen J, Stern LJ. 2002. Soluble peptide-MHC monomers cause activation of CD8+ T cells through transfer of the peptide to T cell MHC molecules. Proc Natl Acad Sci USA 99(21):13729-13734.
14. Germain RN, Rinker AG, Jr. 1993. Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules. Nature 363(6431):725-728.
15. Holler PD, Holman PO, Shusta EV, O'Herrin S, Wittrup KD, Kranz DM. 2000. In vitro evolution of a T cell receptor with high affinity for peptide/MHC. Proc Natl Acad Sci USA 97(10):5387-5392.
16. Holler PD, Chlewicki LK, Kranz DM. 2003. TCRs with high affinity for foreign pMHC show self-reactivity. Nat Immunol 4(1):55-62.
17. Hoogenboom HR. 2002. Overview of antibody phage-display technology and its applications. Methods Mol Biol 178:1-37.
18. Horejsi V, Nemec M, Angelisova P, Kristofova H, Gorga JC, Hilgert I. 1986. Characterization of seven new monoclonal antibodies against human DR, DR + DP and DQ1 + DQ3 antigens. Tissue Antigens 28(5):288-297.
19. Huan J, Subramanian S, Jones R, Rich C, Link J, Mooney J, Bourdette DN, Vandenbark AA, Burrows GG, Offner H. 2004. Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch. J Immunol 172(7):4556-4566.
20. Jacobelli J, Andres PG, Boisvert J, Krummel MF. 2004. New views of the immunological synapse: Variations in assembly and function. Curr Opin Immunol 16(3):345-352.
21. Kappler JW, Skidmore B, White J, Marrack P. 1981. Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition. J Exp Med 153(5):1198-1214.
22. Kieke MC, Shusta EV, Boder ET, Teyton L, Wittrup KD, Kranz DM. 1999. Selection of functional T cell receptor mutants from a yeast surface-display library. Proc Natl Acad Sci USA 96(10):5651-5656.
23. Ketzin BL, Falta MT, Crawford F, Rosloniec EF, Bill J, Marrack P, Kappler J. 2000. Use of soluble peptide-DR4 tetramers to detect synovial T cells specific for cartilage antigens in patients with rheumatoid arthritis. Proc Natl Acad Sci USA 97(1):291-296.
24. Kozono H, White J, Clements J, Marrack P, Kappler J. 1994. Production of soluble MHC class II proteins with covalently bound single peptides. Nature 369(6476):151-154.
25. Kurokawa MS, Ohoka S, Matsui T, Sekine T, Yamamoto K, Nishioka K, Kato T. 2002. Expression of MHC class I molecules together with antigenic peptides on filamentous phages. Immunol Lett 80(3):163-168.
26. Lamb JR, Eckels DD, Lake P, Woody JN, Green N. 1982. Human T cell clones recognize chemically synthesized peptides of influenza haemagglutinin. Nature 300(5887):66-69.
27. LaPan KE, Klapper DG, Frelinger JA. 1992. Production and characterization of two new mouse monoclonal antibodies reactive with denatured mouse class II beta chains. Hybridoma 11(2):217-223.
28. Le Doussal J, Piqueras B, Dogan I, Debre P, Gorochov G. 2000. Phage display of peptide/major histocompatibility complex. J Immunol Methods 241(1-2):147-158.
29. Lee SJ, Hori Y, Groves JT, Dustin ML, Chakraborty AK. 2002. Correlation of a dynamic model for immunological synapse formation with effector functions: Two pathways to synapse formation. Trends Immunol 23(10):492-499.
30. Lee KH, Dinner AR, Tu C, Campi G, Raychaudhuri S, Varma R, Sims TN, Burack WR, Wu H, Wang J, et al. 2003a. The immunological synapse balances T cell receptor signaling and degradation. Science 302(5648):1218-1222.
31. Lee SJ, Hori Y, Chakraborty AK. 2003b. Low T cell receptor expression and thermal fluctuations contribute to formation of dynamic multifocal synapses in thymocytes. Proc Natl Acad Sci USA 100(8):4383-4388.
32. Lin Y, Tsumuraya T, Wakabayashi T, Shiraga S, Fujii I, Kondo A, Ueda M. 2003. Display of a functional hetero-oligomeric catalytic antibody on the yeast cell surface. Appl Microbiol Biotechnol 62(2-3):226-232.
33. Mescher MF. 1992. Surface contact requirements for activation of cytotoxic T lymphocytes. J Immunol 149(7):2402-2405.
34. Minter LM, Osborne BA. 2003. Cell death in the thymus-it's all a matter of contacts. Semin Immunol 15(3):135-144.
35. Monks CR, Freiberg BA, Kupfer H, Sciaky N, Kupfer A. 1998. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 395(6697):82-86.
36. Novak EJ, Liu AW, Gebe JA, Falk BA, Nepom GT, Koelle DM, Kwok WW. 2001. Tetramer-guided epitope mapping: Rapid identification and characterization of immunodominant CD4+ T cell epitopes from complex antigens. J Immunol 166(11):6665-6670.
37. Pluckthun A, Schaffitzel C, Hanes J, Jermutus L. 2000. In vitro selection and evolution of proteins. Adv Protein Chem 55:367-403.
38. Reijonen H, Kwok WW. 2003. Use of HLA class II tetramers in tracking antigen-specific T cells and mapping T cell epitopes. Methods 29(3):282-288.
39. Rotzschke O, Falk K, Mack J, Lau JM, Jung G, Strominger JL. 1999. Conformational variants of class II MHC/peptide complexes induced by N- and C-terminal extensions of minimal peptide epitopes. Proc Natl Acad Sci USA 96(13):7445-7450.
40. Schatz PJ. 1993. Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: A 13 residue consensus peptide specifies biotinylation in Escherichia coli. Biotechnology (NY) 11(10):1138-1143.
41. Shen ZM, Wang L, Pike J, Jue CK, Zhao H, de Nobel H, Kurjan J, Lipke PN. 2001. Delineation of functional regions within the subunits of the Saccharomyces cerevisiae cell adhesion molecule a-agglutinin. J Biol Chem 276(19):15768-15775.
42. Shusta EV, Holler PD, Kieke MC, Kranz DM, Wittrup KD. 2000. Directed evolution of a stable scaffold for T cell receptor engineering. Nat Biotechnol 18(7):754-759.
43. Skinner PJ, Daniels MA, Schmidt CS, Jameson SC, Haase AT. 2000. Cutting edge: In situ tetramer staining of antigen-specific T cells in tissues. J Immunol 165(2):613-617.
44. Starwalt SE, Masteller EL, Bluestone JA, Kranz DM. 2003. Directed evolution of a single-chain class II MHC product by yeast display. Protein Eng 16(2):147-156.
45. Stern LJ, Wiley DC. 1994. Antigenic peptide binding by class I and class II histocompatibility proteins. Structure 2(4):245-251.
46. van den Beucken T, Pieters H, Steukers M, van der Vaart M, Ladner RC, Hoogenboom HR, Hufton SE. 2003. Affinity maturation of Fab antibody fragments by fluorescent-activated cell sorting of yeast-displayed libraries. FEBS Lett 546(2-3):288-294.
47. Vest Hansen N, Ostergaard Pedersen L, Stryhn A, Buus S. 2001. Phage display of peptide/major histocompatibility class I complexes. Eur J Immunol 31(1):32-38.
48. Weaver-Feldhaus JM, Lou J, Coleman JR, Siegel RW, Marks JD, Feldhaus MJ. 2004. Yeast mating for combinatorial Fab library generation and surface display. FEBS Lett 564(1-2):24-34.
49. Weidanz JA, Card KF, Edwards A, Perlstein E, Wong HC. 1998. Display of functional alphabeta single-chain T cell receptor molecules on the surface of bacteriophage. J Immunol Methods 221(1-2):59-76.
50. Wittrup KD. 2001. Protein engineering by cell-surface display. Curr Opin Biotechnol 12(4):395-399.
51. Zaru R, Cameron TO, Stern LJ, Muller S, Valitutti S. 2002. Cutting edge: TCR engagement and triggering in the absence of large-scale molecular segregation at the T cell-APC contact site. J Immunol 168(9):4287-4291.
52. Zarutskie JA, Sato AK, Rushe MM, Chan IC, Lomakin A, Benedek GB, Stern LJ. 1999. A conformational change in the human major histocompatibility complex protein HLA-DRI induced by peptide binding. Biochemistry 38(18):5878-5887.